• 
• See all for Zacks.com
• View Print Version

More from Zacks.com

• Intuitive Surgical Beats on Higher Revs - Analyst Blog
• Align's Earnings Beat Ests, Revs Grow - Analyst Blog
• Healthways Reports Loss in 1Q13 - Analyst Blog

Referenced Stocks

• ALGN 100% Rate It

Align Technology, Inc. ( ALGN ) reported a strong second quarter with both revenues and earnings sailing past the Zacks Consensus Estimates, on the back of its flagship product, Invisalign. Growth was boosted by increased patient visits and a growing interest among the teenage patient population.

In addition, contribution from Cadent helped Align to further penetrate the malocclusion market. The growth momentum is expected to sustain as scanner sales and opportunities in the digital dentistry and restorative markets rise.

The company's focus on the international market, especially in Europe and China, is encouraging. Rising earnings estimates and a product with great appeal and untapped potential, in the malocclusion market make us optimistic about Align. Accordingly, we upgrade the stock to Outperform.
 
ALIGN TECH INC (ALGN): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Related Stocks Articles

• 
  Video Game Sales Plunge in April - Analyst Blog
  5/24/2013 05:26 PM
• 
  Promising Data on ONCY's Reolysin - Analyst Blog
  5/24/2013 05:26 PM
• 
  How to Beat THIS Market - Weekend Wisdom
  5/24/2013 05:26 PM